IASLC and ESMO Present 6th European Lung Cancer Conference

6th European Lung Cancer Conference

By Nicola M. Parry, DVM

From April 13-16, 2016, the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO) will once again join forces to host the 6th European Lung Cancer Conference (ELCC) at Palexpo in Geneva, Switzerland. This
meeting is a collaborative effort of key multidisciplinary societies representing thoracic oncology specialists—all working to advance science, provide education, and enhance the practice of lung cancer specialists worldwide. It plays a key role in providing an updated overview of prevention, screening, diagnosis, and treatment of lung cancer, as well as
results of basic, clinical, and translational research.

Now held annually, ELCC is an important conference in Europe for all clinicians involved in the diagnostic workup and treatment of lung cancer and other thoracic malignancies. The
conference attracts a diverse audience that includes medical oncologists, radiotherapists, thoracic surgeons, respiratory physicians, interventional radiologists, and pathologists. In this way, the meeting aims to foster productive multidisciplinary interaction among specialists in order to strengthen an integratedapproach to diagnosis and treatment of lung and other thoracic cancers.

During the 4-day program, an internationally renowned faculty of thoracic oncology specialists will present updates on a variety of topics that address the scientific and educational needs of clinician attendees who treat these cancers.
This year’s meeting will highlight several themes. These include advances in immunotherapy, stereotactic radiation therapy, the treatment of molecularly defined non-small cell lung cancer, cancer screening, and minimally invasive local treatments. The new World Health Organization classification of lung tumors will also be featured, including its impact on patient care, from both the surgeon’s and pathologist’s viewpoint. The new IASLC staging system will also be discussed.

More than 1,600 international clinicians are expected to attend this year’s meeting, and throughout the conference, attendees can share updates from the meeting on social media using the dedicated #ELCC16 hashtag. The meeting will also feature eight industry satellite symposia and a wide range of commercial exhibitors, and will provide excellent opportunities for networking.

IASLC Lung Cancer News, this new professional tabloid publication targeted to thoracic cancer specialists, will also be launching at this meeting; conference delegates are encouraged to stop by and see us at the IASLC booth.